1 / 15

Non- arboviruses associated with zoonotic diseases

Non- arboviruses associated with zoonotic diseases. Dr. Mohammed Arif. Associate professor and consultant virologist. Non- arboviruses zoonotic diseases. 1– Lassa virus ( family: Arenaviridae). 2– Hantavirus ( family : Bunyaviridae ). 3– Machupovirus( Bolivian hemorrhagic fever).

wilbur
Télécharger la présentation

Non- arboviruses associated with zoonotic diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Non-arboviruses associated with zoonotic diseases Dr. Mohammed Arif. Associate professor and consultant virologist.

  2. Non-arboviruses zoonotic diseases. 1– Lassa virus ( family: Arenaviridae). 2– Hantavirus ( family : Bunyaviridae ). 3– Machupovirus( Bolivian hemorrhagic fever). 4– Junín virus ( Argentinean hemorrhagic fever ).

  3. 1--- Lassa fever Caused by Lassa virus. The virus was discovered in 1969, in Nigeria . Family : arenaviridae. Enveloped, ss-RNA genome

  4. Transmission The animal reservoir for the virus is rodent known as the multi-mammal rat. Infected rodents shed the virus in their excreta. Humans are infected by direct contact with rodents excreta, or eating foods contaminated with these excreta. Also, transmission occurs through inhalation of tiny particles contaminated with rodents excreta.

  5. Transmission Person to person transmission occurs by direct contact with infected blood and body fluids. Through contaminated medical instruments .

  6. Clinical features Incubation period: 6 – 21 days. Lassa fever is an acute viral hemorrhagic fever. Characterized by multi-organ dysfunction . The disease starts with fever , facial swelling, fatigue, nausea, myalgia,vomiting, diarrhea, cough, dyspnea, encephalitis , tremors and mucosal bleeding . Mortality rate : 15 -20 % .

  7. prognosis About 80 % of infected individuals shown no symptoms or had mild illness. The remaining 20 % develop severe multi – systemic diseases and hemorrhage . Mortality rate is about 15- 20 % .

  8. Lab diagnosis Must be accomplished under maximum biological containment conditions. Isolation of the virus in tissue culture, followed by identification of the isolated virus. Detection of the viral RNA in the patient blood using PCR .

  9. Treatment & prevention There is no specific anti-viral drug therapy. Treatment is supportive. Prevention: By controlling rodents. There is no vaccine available yet .

  10. Hantavirus Family: Bunyaviridae . Genus : Hantavirus . The virus is enveloped . The viral genome is ss-RNA , three segments, with negative polarity.

  11. Transmission Hantavirus is carried by a rodent known with deer mice . The virus is excreted in the urine, saliva and feces of infected mice . Humans are infected when they come in direct contact with rodents excreta . No human to human transmission has been recorded

  12. Types of diseases. Hantavirus infection ranges from mild to severe . Severe cases may take the form of: 1- Renal hemorrhagic syndrome ( RHS ). 2- Hanta pulmonary syndrome ( HPS ) .

  13. 1- Renal hemorrhagic syndrome ( RHS ) . Incubation period : 1-5 weeks. The disease ranges from mild cases to severe . The virus infects the endothelial cells in the kidney. Severe disease characterized by fever, headache, nausea, vomiting, abdominal pain, conjunctivitis, hypotension, hemorrhage, renal impairment, proteinuria and oliguria

  14. 2- Hanta pulmonary syndrome ( HPS ). The disease ranges from mild cases to severe . The dieses is characterized by fever , chills, myalgia, headache, nausea, vomiting, sore throat, coryza, tachycardia, shortness of breath, dyspnea, pleural effusion and hemorrhage . The virus causes damage to the pulmonary micro vascular endothelium, increasing capillary permeability and pulmonary edema . Complication : cardio-respiratory failure . Mortality rate is about 30 – 40 % .

  15. Lab diagnosis 1 -- By isolation of the virus in tissue culture, followed by identification of the isolated virus . 2– by detection of the viral – RNA , using PCR .

More Related